500th Edition, March 22, 2022

Trouble Viewing This Email: Click Here

March 22, 2022

FOUNDING MEMBER OF

Darryll J. Pines, President, University of Maryland, Visits with Rich Bendis on BioTalk

Darryll J. Pines, President, University of Maryland, Joins BioTalk to discuss all things relating the University to the BioHealth Capital Region from Quantum to Workforce Development to Diversity and Equality

Listen now on Apple https://apple.co/3Iq9gqf, Google https://bit.ly/37NHFms, Spotify https://spoti.fi/3KZNziz, Amazon https://amzn.to/3ImyYvP, and TuneIn https://bit.ly/3IrYakN

Darryll J. Pines serves as president of the University of Maryland as well as the Glenn L. Martin Professor of Aerospace Engineering.

Formerly the Nariman Farvardin Professor of Engineering and dean of UMD’s A. James Clark School of Engineering, where he has been on the faculty since 1995, Pines amassed a record of academic leadership and research accomplishments that have dramatically elevated the school’s rankings and stature nationally and internationally. In 2019, he was elected to the National Academy of Engineering for his “inspirational leadership and contributions to engineering education.”

Approved Opportunity Zone Incentive Program will Attract and Retain Biohealth Companies in Montgomery County

ROCKVILLE, Md., March 15, 2022—Today the Council voted on a resolution spearheaded by Councilmembers Andrew Friedson and Nancy Navarro to create a Biohealth Opportunity Zone Incentive Program which will provide grants to attract Biohealth Priority Campuses to the County’s Opportunity Zones.

The Biohealth Opportunity Zone Incentive Program approved today by the Council will provide a grant of $250,000 to any Biohealth Priority Campus located in a County Opportunity Zone, upon its receipt and occupancy permit.

BioHealth Innovation and the BioHealth Capital Region Remembers Juvale (Jae) Regala

BioHealth Innovation and the BioHealth Capital Region mourn the loss of TaylorMade Experience LLC (TME) COO Juvale Regala (Jae). Jae has been an integral part of the annual BioHealth Capital Region Forum and Investment Conference, contributing to both events' planning and implementation. Without Jae's dedication, professionalism, and kindness, these events wouldn't have been the successes they were over the years. As a stage 4 acute lymphoblastic leukemia, Jae was a fighter for herself and her four daughters. As a result, a gofundme has been created to help her family financially during these difficult times. Please visit https://bit.ly/JaeRegala to donate to this worthy cause. Our deepest condolences to Jae's family and the TME team. We miss you, Jae.

Rich Bendis, President & CEO, BioHealth Innovation

Maryland Tech Council Receives $2.45 Million in Federal Funds to Propel Tech & Life Sciences Innovation in Maryland With BioHub Maryland | Business Wire

FREDERICK, Md.–(BUSINESS WIRE)–The Maryland Tech Council, the largest technology and life sciences trade association in the state, today announced it has received $2.45 million in federal funding to accelerate innovation in Maryland. The community project funding is included in the fiscal year 2022 omnibus appropriations bill and made possible by the leadership of Senator Chris Van Hollen (MD), chair of the Senate Appropriations Financial Services and General Government subcommittee.

The medicines supply chain: Increasing visibility to strengthen preparedness | Quality Matters | U.S. Pharmacopeia Blog

March 11 marked the sobering two-year anniversary of the World Health Organization’s declaration of COVID-19 as a global pandemic. COVID-19 made clear that it can’t be business-as-usual with the medicines supply chain, not when lives are at stake. Since then, policymakers in Washington have committed billions of dollars to address vulnerabilities in pandemic preparedness infrastructure.

DMV Healthcare Gamechangers – The Monthly Blend

Sally Allain, Head of JLABS @ Washington, DC, and Dr. Kurt Newman, Pres/CEO of Children’s National Hospital sit down with Tien and Anthony to discuss how JLABS and Children’s National are impacting pediatric healthcare in our region and nationally, and why they partnered to create a research and innovation campus at the old Walter Reed Army base.

Image: https://jlabs.jnjinnovation.com/about-us/team/sally-allain

NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center

GAITHERSBURG, MD, March 14, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced a research and evaluation collaboration with The Laura and Isaac Perlmutter Cancer Center, a National Cancer Institute designated Comprehensive Cancer Center and part of NYU Langone Health. The collaboration is centered around NexImmune’s artificial antigen presenting cells' (aAPCs) ability to expand neoantigen-specific CD8+ T cells in apheresis material provided by melanoma patients. Dr. Jeffrey S. Weber, Deputy Director of the Laura and Isaac Perlmutter Cancer Center will guide the research and evaluation.

NOVA Bioscience Center Grand Opening

The Prince William County Department of Economic Development, in partnership with Holladay Properties, cordially invites you to the Northern Virginia Bioscience Center Grand Opening Celebration on March 29, 2022 at 11:30 a.m.

Join us to commemorate the completion of 30,000 square feet in new commercial wet lab space reflecting more than $17.3 million in capital investment. Meet with elected officials from the Board of County Supervisors, GMU faculty and researchers, biotech business owners, and many more.

Lunch will be provided with attendee giveaways and opportunities to tour tenant spaces. Attendance is free, but please RSVP at pwcded.org/nvbc-rsvp by Friday, March 25, to advise of your attendance. We hope to see you there!

RSVP Here

SXSW 2022 Announces Winners of 14th Annual Pitch Event

“What do you envision for your company’s future?” is a typical question for startups. And many of the 45 companies pitching in nine categories during the 14th annual SXSW Pitch Event showed they had a clear strategy for where they want to take their business next.

But no matter what the future holds, we all benefit from the inspired and imaginative minds solving today’s problems in both emerging and traditional industries like artificial intelligence and robotics, health, immersive, and transportation.

Thermo Fisher Scientific to Expand Clinical Research Labs’ Capacity in Virginia

New investment will enhance immunochemistry and chromatography services, helping pharma and biotech customers accelerate drug development

March 14, 2022 08:36 AM Eastern Daylight Time

WILMINGTON, N.C.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will invest $97 million to expand its clinical research operations in Richmond, Virginia. The facilities, which include laboratory operations acquired with the purchase of PPD, Inc. in December 2021, will support increasing demand across biopharma for consistent, high-quality laboratory services to accelerate drug development.

What kills innovation? 4 hospital innovation leaders weigh in

To make innovation a priority, hospitals and health systems must harness innovation efforts from the pandemic to stay ahead of the curve. Here, four health system and hospital innovation leaders share habits that are killing innovation.

Christine Brocato. System VP, Strategic Innovation of CommonSpirit Health (Chicago). Health systems are just recovering from the last COVID surge and there's a lot of concern about staffing levels and financials, which has hindered innovation as health systems have been focusing on immediate issues rather than future investments in innovation.

The U.S. just created a big new biomedical research agency. But questions remain | Science | AAAS

President Joe Biden last week got his wish for a new agency to fund high-risk, cutting-edge biomedical research when Congress created the Advanced Research Projects Agency for Health (ARPA-H) and gave it a $1 billion startup investment. That’s a fraction of the $6.5 billion Biden had proposed, but advocates say it’s plenty to launch ARPA-H.

The 2022 spending bill does not resolve, however, a debate over whether to make ARPA-H a standalone agency within the Department of Health and Human Services (HHS) or part of the National Institutes of Health (NIH). Instead, it gives HHS Secretary Xavier Becerra 30 days to decide.

Image: https://no.wikipedia.org/wiki/Francis_Collins

Prospects for Transatlantic Cooperation in Biotech Policy—A U.S. Perspective | ITIF

Mutual self-interest provides a strong basis for transatlantic cooperation in biotechnology based on shared recognition of its vast potential to provide solutions to some of civilization’s most pressing problems. Thanks to explosive advances in our understanding of the many ways in which promiscuous nature has been manipulating DNA and RNA for the past billion years, it is widely anticipated that the 21st century will belong to biology.1 We are now at the point where our ability to innovate is constrained less by technical capability than by the limits of our imaginations. Multiple laboratories and companies on both sides of the Atlantic (and throughout the world) are pursuing promising applications, and experience confirms progress would be accelerated by cooperative approaches. But there are some considerable challenges, especially in agricultural and industrial contexts.

Johns Hopkins sets its sights on a new strategic vision | Hub

Two years after beginning a collaborative strategic visioning process, only to pause in response to the urgent demands of the COVID-19 pandemic, Johns Hopkins University is relaunching the work of evaluating Johns Hopkins' Ten by Twenty strategic vision and mapping the next phase of the university's future.

Open Position: Ventures Analyst and Project Manager at NIH SEED Office

BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets. BHI is seeking a life science business analyst to support the NIH SEED Office (https://seed.nih.gov/). The analyst will provide business landscape analysis and other project support on product development, corporate strategy, and private investment for NIH-funded companies. This will entail market landscape, technology, and other business intelligence research to support Entrepreneur-in-Residence and other SEED life science commercialization activities.

Download the PDF of the job description.

View on LinkedIn

View on Indeed

Leave a Reply Cancel Reply

About BioHealth Innovation

Contact

Connect